COTI-2

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H22N6S
Molecular Weight	366.483
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

S=C(N\N=C1/CCCC2=CC=CN=C12)N3CCN(CC3)C4=NC=CC=C4

InChI

InChIKey=UTDAKQMBNSHJJB-CJLVFECKSA-N

InChI=1S/C19H22N6S/c26-19(23-22-16-7-3-5-15-6-4-10-21-18(15)16)25-13-11-24(12-14-25)17-8-1-2-9-20-17/h1-2,4,6,8-10H,3,5,7,11-14H2,(H,23,26)/b22-16+

HIDE SMILES / InChI

Molecular Formula	C19H22N6S
Molecular Weight	366.483
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	1
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28756138 | https://clinicaltrials.gov/ct2/show/NCT02433626 | http://cotingapharma.com/pipeline/coti-2/

COTI-2 is an orally available small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers. The drug was developed by Clinical Outcome Technologies Inc (now Cotinga Pharmaceuticals) and is believed to act by reactivating mutant p53 and inhibiting the phosphatidylinositol 3-kinase (PI3K)/Akt. The drug is being evaluated in phase I clinical trials for the treatment of gynecologic cancers and head and neck squamous cell carcinoma.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Pyruvate dehydrogenase kinase 4 Target ID: CHEMBL2096665 Sources: https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20180215&CC=WO&NR=2018031407A1&KC=A1	Inhibitor 8504
Cellular tumor antigen p53 21 Target ID: CHEMBL4096 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28756138	Activator 1447

Substance Class	Chemical Created by `admin` on `Mon Mar 31 22:58:12 GMT 2025` Edited by `admin` on `Mon Mar 31 22:58:12 GMT 2025`
Record UNII	2BTA1O65BR
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

1-PIPERAZINECARBOTHIOIC ACID, 4-(2-PYRIDINYL)-, 2-(6,7-DIHYDRO-8(5H)-QUINOLINYLIDENE)HYDRAZIDE

Preferred Name

English

COTI-2

Code

English

COTI 2 [WHO-DD]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

434314